Roivant Sciences Ltd

23 oct. 2023, 19:26 UTC

Trending: Roche to Buy Telavant From Roivant and Pfizer

23 oct. 2023, 08:01 UTC

Roche to Buy Telavant From Roivant, Pfizer in Deal Worth Up to $7.25 Billion -- Update

23 oct. 2023, 05:35 UTC

Roche to Buy Telavant From Roivant Sciences and Pfizer in $7.25 Billion Deal

27 mars 2024, 13:51 UTC

Stocks to Watch Wednesday: Carnival, Robinhood, Trump Media, Merck -- WSJ

27 mars 2024, 10:16 UTC

Stocks to Watch Wednesday: GameStop, Robinhood, Merck, Carnival -- WSJ

14 déc. 2023, 14:03 UTC

Roche Completes Acquisition of Telavant From Roivant, Including Rights to Novel TL1A Directed Antibody (RVT-3101) for the Treatment of Inflammatory Bowel Disease

24 oct. 2023, 12:00 UTC

This $5 Billion Biotech Home Run Took Less Than a Year -- Heard on the Street -- WSJ

23 oct. 2023, 20:05 UTC

Roche Follows Merck, Sanofi Into A Red-Hot Immunology Space With A $7.1 Billion Buyout -- IBD

23 oct. 2023, 15:30 UTC

Roche Follows Merck, Sanofi Into A Red-Hot Immunology Space With A $7.1 Billion Buyout -- IBD

23 oct. 2023, 10:55 UTC

Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion -- Update

23 oct. 2023, 08:44 UTC

These Stocks Are Moving the Most Today: Roivant Sciences, Textainer, Okta, Microsoft, Alphabet -- Barrons.com

23 oct. 2023, 08:17 UTC

Roche's Acquisition Could Start to Turn Sentiment Around -- Market Talk